CUSIP 578784100COMMAZEQ4 2025
20 filings · latest Feb 13, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 4.57M | $189.22M |
| 2 | Trv Gp IV, LLC | 4.47M | $185.36M |
| 3 | Deep Track Capital, LP | 4.25M | $175.93M |
| 4 | Arch Venture Management, LLC | 4.12M | $170.69M |
| 5 | Janus Henderson Group PLC | 3.14M | $130.20M |
| 6 | Blackrock, Inc. | 2.29M | $94.76M |
| 7 | A16z Capital Management, L.L.C. | 1.70M | $70.52M |
| 8 | Vanguard Group Inc | 1.70M | $70.31M |
| 9 |
| 4 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 7.3% | 3.21M | SEC |
| 5 | Nov 14, 2025 | Foresite Capital Fund IV, L.P. | 13G/A | 11.0% | 608.9K | SEC |
| 6 | Nov 13, 2025 | Matrix Capital Management Company, LP | 13G/A | 3.5% | 1.65M | SEC |
| 7 | Aug 14, 2025 | Frazier Life Sciences Public Fund, L.P. | 13G/A | 7.7% | 3.35M | SEC |
| 8 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 6.0% | 2.63M | SEC |
| 9 | Aug 14, 2025 | Deep Track Capital, LP | 13G/A | 9.0% | 3.95M | SEC |
| 10 | May 15, 2025 | Arch Venture Fund X, L.P. | 13G | 9.4% | 4.12M | SEC |
See the full Schedule 13D/13G history for Maze Therapeutics Inc.
Unlock full history| Vr Adviser, LLC |
| 1.55M |
| $64.16M |
| 10 | Alphabet Inc. | 1.39M | $57.53M |